비교리스트

 카트 문의
시장보고서
상품코드
1678472

세계의 바이오인포매틱스 서비스 시장 : 시장 규모, 점유율, 동향 분석(유형별, 용도별, 부문별, 지역별), 부문별 예측(2025-2030년)

Bioinformatics Services Market Size, Share & Trends Analysis Report By Type (NGS, Chemoinformatics, Microarray Data Analysis, Biological Data Curation), By Application (Proteomics, Metabolomics), By Sector, By Region, And Segment Forecasts, 2025 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

바이오인포매틱스 서비스 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 바이오인포매틱스 서비스 시장 규모는 2025년부터 2030년까지 14.46%의 연평균 복합 성장률(CAGR)을 나타내고, 2030년에는 71억 1,000만 달러에 이를 것으로 예상됩니다. 세포 신호전달, 경로 대사, 유전자 수용체 상호작용, 표적 분화 등 다양한 연구에 IT 솔루션의 채택이 확대되면서 예측 기간 동안 이 시장의 성장을 가속할 것으로 보입니다.

실험실의 프로토콜 작성, 데이터 관리, 분석에 정보화 솔루션을 사용하는 장점으로 인해 향후 몇 년동안 이러한 솔루션은 큰 수요가 있을 것으로 예상됩니다.

또한, 온라인 데이터 저장 및 컴퓨터 자원의 가시화 등 클라우드 컴퓨팅과 관련된 주요 기술을 개발 및 흡수하기 위해 정보기술 기업들이 제약회사 및 임상연구기관과 함께 진행하는 공동 활동은 2024년까지 시장 잠재력을 높일 것으로 예상됩니다.

바이오인포매틱스 서비스 시장 : 분석 개요

  • NGS 부문은 2024년 34.85%의 가장 큰 시장 수익 점유율을 차지하며 예측 기간 동안 가장 높은 CAGR을 나타냈습니다. 과학 소프트웨어 테스트 분야는 예측 기간 동안 높은 CAGR을 나타낼 것으로 예상됩니다.
  • 신약 개발 응용 분야는 2024년 24.68%의 가장 큰 시장 수익 점유율을 차지했습니다. 단백질체학 분야는 예측 기간 동안 가장 높은 CAGR을 나타낼 것으로 예상됩니다.
  • 학술 분야는 2024년 가장 큰 시장 수익 점유율을 차지했습니다. 동물 분야는 예측 기간 동안 큰 성장을 보일 것으로 예상됩니다.
  • 북미 바이오인포매틱스 서비스 시장은 2024년 45.70% 시장 점유율로 업계를 지배했습니다. 아시아태평양의 바이오인포매틱스 서비스 산업은 예측 기간 동안 가장 빠른 CAGR을 보일 것으로 예상됩니다.

목차

제1장 분석 방법, 범위

제2장 주요 요약

제3장 바이오인포매틱스 서비스 시장 : 변동 요인, 경향, 범위

  • 시장 연관 전망
    • 상위 시장 전망
    • 관련/부수 시장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 업계 분석 툴
    • Porter의 Five Forces 분석
    • PESTEL 분석
    • COVID-19의 영향 분석

제4장 바이오인포매틱스 서비스 시장 : 유형별 추정, 동향 분석

  • 유형별 대시보드
  • 세계의 바이오인포매틱스 서비스 시장 변동 분석 : 유형별
  • 세계의 바이오인포매틱스 서비스 시장 규모와 동향 분석 : 유형별(2018-2030년)
  • NGS(차세대 시퀀싱)
    • 타겟 시퀀싱 분석
    • 트란스크리프토무 해석
    • 전장 유전체
    • 칩 시퀀싱 분석
    • De novo Assembly
    • 메틸 시퀀싱 분석
  • 화학정보학
    • 배열 분석 플랫폼
    • 분자 모델링
    • 도킹
    • 임상시험 데이터 관리
    • 기타
  • 마이크로어레이 데이터 분석
  • 생물학적 데이터 큐레이션
  • 과학적 소프트웨어 테스트
  • 기타 서비스

제5장 바이오인포매틱스 서비스 시장 : 용도별 추정, 동향 분석

  • 용도별 대시보드
  • 세계의 바이오인포매틱스 서비스 시장 변동 분석 : 용도별
  • 세계의 바이오인포매틱스 서비스 시장 규모와 동향 분석 : 용도별(2018-2030년)
  • 유전체학
  • 전사체학
  • 단백질체학
  • 대사체학
  • Drug Discovery
  • 기타

제6장 바이오인포매틱스 서비스 시장 : 부문별 추정, 동향 분석

  • 부문별 대시보드
  • 세계의 바이오인포매틱스 서비스 시장 변동 분석 : 부문별
  • 세계의 바이오인포매틱스 서비스 시장 규모와 동향 분석 : 부문별(2018-2030년)
  • 의학
  • 동물
  • 농업
  • 학술

제7장 바이오인포매틱스 서비스 시장 : 지역별 추정, 동향 분석

  • 지역별 시장 점유율 분석(2024년, 2030년)
  • 지역별 시장 대시보드
  • 시장 규모 예측과 동향 분석(2018-2030년)
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 호주
    • 태국
    • 한국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제8장 경쟁 구도

  • 참여 기업
  • 기업 시장 포지션 분석(2024년)
  • 참여 기업 개요
    • Agilent Technologies, Inc.
    • BGI Group
    • Dotmatics
    • Labvantage-Biomax GmbH
    • CD Genomics
    • Creative Biolabs
    • DNAnexus, Inc.
    • DNASTAR
    • Fios Genomics
    • Illumina, Inc.
    • PerkinElmer Inc.
    • QIAGEN
    • Thermo Fisher Scientific Inc.
LSH 25.04.02

Bioinformatics Services Market Growth & Trends:

The global bioinformatics services market size is expected to reach USD 7.11 billion by 2030, registering a CAGR of 14.46% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing adoption of I.T. solutions for different studies such as cell signaling, pathway metabolism, gene-receptor interactions, and target differentiation are expected to support growth in this market over the forecast period.

Owing to the benefits associated with the use of informatic solutions for laboratory protocol generation and data management as well as analysis, these solutions are projected to witness substantial demand in the coming years.

Moreover, collaborative activities undertaken by the information technology companies with pharmaceutical companies and clinical research organizations in order to develop and update key technologies linked to cloud computing, like online data storage and visualization of computer resources are expected to enhance market potential through to 2024.

Bioinformatics Services Market Report Highlights:

  • The NGS segment accounted for the largest market revenue share of 34.85% in 2024 and is expected to register the largest CAGR during the forecast period. The scientific software testing segment is expected to register significant CAGR during the forecast period.
  • The drug discovery application segment accounted for the largest market revenue share of 24.68% in 2024. The proteomics segment is expected to witness the highest CAGR over the forecast period.
  • The academic segment accounted for the largest market revenue share in 2024. The animal sector is expected to witness significant growth over the forecast period.
  • North America bioinformatics services market dominated the industry in 2024 with market share of 45.70%. The Asia Pacific bioinformatics services industry is expected to witness the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. Sector
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Biohacking Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Demand for Precision Medicine & Genomic Research
      • 3.2.1.2. Rising Investments & Government Initiatives
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Costs & Data Security Concerns
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Bioinformatics Services Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Global Bioinformatics Services Market Type Movement Analysis
  • 4.3. Global Bioinformatics Services Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. NGS
    • 4.4.1. NGS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Targeted Sequencing Analysis
      • 4.4.2.1. Targeted Sequencing Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Transcriptome Analysis
      • 4.4.3.1. Transcriptome Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Whole Genome
      • 4.4.4.1. Whole Genome Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Chip Seq Analysis
      • 4.4.5.1. Chip Seq Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. De novo Assembly
      • 4.4.6.1. De novo Assembly Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.7. Methyl Seq Analysis
      • 4.4.7.1. Methyl Seq Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Chemoinformatics
    • 4.5.1. Chemoinformatics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Sequence Analysis Platforms
      • 4.5.2.1. Sequence Analysis Platforms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Molecular Modeling
      • 4.5.3.1. Molecular Modeling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Docking
      • 4.5.4.1. Docking Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Clinical trial data management
      • 4.5.5.1. Clinical Trial Data Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Microarray Data Analysis
    • 4.6.1. Microarray Data Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Biological Data Curation
    • 4.7.1. Biological Data Curation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Scientific Software Testing
    • 4.8.1. Scientific Software Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Other Services
    • 4.9.1. Other Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bioinformatics Services Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Bioinformatics Services Market Application Movement Analysis
  • 5.3. Global Bioinformatics Services Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Genomics
    • 5.4.1. Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Transcriptomics
    • 5.5.1. Transcriptomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Proteomics
    • 5.6.1. Proteomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Metabolomics
    • 5.7.1. Metabolomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Drug Discovery
    • 5.8.1. Drug Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Bioinformatics Services Market: Sector Estimates & Trend Analysis

  • 6.1. Sector Segment Dashboard
  • 6.2. Global Bioinformatics Services Market Sector Movement Analysis
  • 6.3. Global Bioinformatics Services Market Size & Trend Analysis, by Sector, 2018 to 2030 (USD Million)
  • 6.4. Medical
    • 6.4.1. Medical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Animal
    • 6.5.1. Animal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Agricultural
    • 6.6.1. Agricultural Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Academics
    • 6.7.1. Academics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Bioinformatics Services Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. North America Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. UK Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Denmark Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Sweden Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Australia Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Thailand Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. South Korea
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. South Korea Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Participant's Overview
    • 8.3.1. Agilent Technologies, Inc.
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. BGI Group
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Dotmatics
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Labvantage - Biomax GmbH
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. CD Genomics
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Creative Biolabs
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. DNAnexus, Inc.
      • 8.3.7.1. Participant's Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. DNASTAR
      • 8.3.8.1. Participant's Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Fios Genomics
      • 8.3.9.1. Participant's Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Illumina, Inc.
      • 8.3.10.1. Participant's Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. PerkinElmer Inc.
      • 8.3.11.1. Participant's Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Product Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. QIAGEN
      • 8.3.12.1. Participant's Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Product Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. Thermo Fisher Scientific Inc.
      • 8.3.13.1. Participant's Overview
      • 8.3.13.2. Financial Performance
      • 8.3.13.3. Product Benchmarking
      • 8.3.13.4. Strategic Initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제